Trademark Search in Canada

TYRVAYA

View On IC.GC.CA

REGISTERED

on 27 Apr 2022

Last Applicant/ Owned by

OYSTER POINT PHARMA INC.

202 Carnegie Center, Suite 106Princeton NJ 08540

Serial Number

2053618 filed on 7^th Aug 2020

Registration Number

TMA1127548 registered on 27^th Apr 2022

Registration expiry Date

7^th Aug 2030

Correspondent Address

OSLER, HOSKIN & HARCOURT LLP

Suite 320, World Exchange Plaza100 Queen StreetOttawa,

ONTARIO

K1P1J9

TYRVAYA

Trademark usage description

pharmaceutical preparations for the treatment of dry eye disease; pharmaceutical preparations for the treatment of neurotropic keratitis; pharmaceutic Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of dry eye disease; Pharmaceutical preparations for the treatment of neurotropic keratitis; pharmaceutical preparations for the treatment of ophthalmological diseases; nasal spray preparations; pharmaceutical preparations in the form of nasal sprays for the treatment of ophthalmological diseases.

Classification kind code

Mark Details

Serial Number

2053618

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 26 on 14^th Jan 2022	Approved
Submitted for opposition 27 on 14^th Jan 2022	Approval Notice Sent
Submitted for opposition 22 on 10^th Jan 2022	Search Recorded
Submitted for opposition 256 on 26^th Jul 2021	Notification of Possible Opposition Sent
Submitted for opposition 48 on 19^th Oct 2020	Agent Changed
Submitted for opposition 257 on 24^th Sept 2020	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 23^rd Sept 2020	Created
Submitted for opposition 31 on 23^rd Sept 2020	Formalized
Submitted for opposition 228 on 7^th Aug 2020	International Registration
Submitted for opposition 30 on 7^th Aug 2020	Filed